US regulators defend requiring more data on monkeypox drug - SABC News - Breaking news, special reports, world, business, sport coverage of all South African current events. Africa's news leader.

  • 📰 SABCNews
  • ⏱ Reading Time:
  • 33 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 51%

Business News News

Business Business Latest News,Business Business Headlines

As US monkeypox cases rise, US health agencies in a medical journal article published on Wednesday defended their decision to require human trial data to show that SIGA Technologies’ experimental drug TPOXX is safe and effective to treat the virus.

Image: Reuters

The FDA approved TPOXX in 2018 for smallpox in adults and children based on studies of animals infected with monkeypox and rabbitpox, as well as safety data in healthy people. It can only be sold to the US Strategic National Stockpile. Although TPOXX was only tested in healthy people, the European Medicines Agency said it expects side effects to be similar in infected people, and deemed the drug’s benefits to be greater than its risks.

On July 21, the CDC and the FDA began allowing doctors to prescribe the drug before the trial paperwork is completed, but still requires approval of a hospital’s institutional review board for each dose.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Just watch SAns queue up to take TPOXX how crazy is that

Andizi

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 37. in BUSİNESS

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Malawi Government Demands U.S.$309.6 Billion From Us Company for Illegal MiningUnder instructions from the Minister of Finance, Malawi's Attorney General, Thabo Chakaka-Nyirenda has written Columbia Gem House of Vancouver, USA demanding US$309.6 billion as claim for unpaid tax revenue in respect of ruby and sapphire minerals extracted from Chimwadzulu Mine in Ntcheu District by the US company's subsidiary, Nyala Mines Limited.
Source: allafrica - 🏆 1. / 99 Read more »